Merro Pharmaceutical Co. Ltd.

Earnings Per Share Growth (%)307.34%
Cost of Goods Sold (US$ Millions)$13,096
Current Liabilities (US$ Millions)$7,470
Total Assets (US$ Millions)$7,307
Long Term Debt$603
Return on Equity206.55%
Revenue (US$ Millions)$14,428
Total Company Assets$11,673
Revenue Growth (%)25121.12%
Net Income (US$ Millions)$306
Earnings Per Share (US$)$307.34
Total Equity (US$ Millions)$3,231
Profit Margin (%)2.12%
Debt To Equity Ratio (%)0.19%
Inventory Turnover$2,147